Ausaf Ahmad

Dr. Ausaf Ahmad

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JLJustin S. Lee
Justin S. Lee
JGJason M. Goldstein
Jason M. Goldstein
JMJonathan L. Moon
Jonathan L. Moon
OHOwen Herzegh
Owen Herzegh
DBDennis A. Bagarozzi
Dennis A. Bagarozzi
DCDarin S. Carroll
Darin S. Carroll
At the start of the COVID-19 pandemic, the Centers for Disease Control and Prevention (CDC) designed, manufactured, and distributed the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel for SARS-CoV-2 detection. The diagnostic panel targeted three viral nucleocapsid gene loci (N1, N2, and N3 primers and probes) to maximize sensitivity and to provide redundancy for virus detection if mutations occurred. After the first distribution of the diagnostic panel, state public health laboratories reported fluorescent signal in the absence of viral template (false-positive reactivity) for the N3 component and to a lesser extent for N1. This report describes the findings of an internal investigation conducted by the CDC to identify the cause(s) of the N1 and N3 false-positive reactivity. For N1, results demonstrate that contamination with a synthetic template, that occurred while the “bulk” manufactured materials were located in a research lab for quality assessment, was the cause of false reactivity in the first lot. Base pairing between the 3’ end of the N3 probe and the 3’ end of the N3 reverse primer led to amplification of duplex and larger molecules resulting in false reactivity in the N3 assay component. We conclude that flaws in both assay design and handling of the “bulk” material, caused the problems with the first lot of the 2019-nCoV Real-Time RT-PCR Diagnostic Panel. In addition, within this study, we found that the age of the examined diagnostic panel reagents increases the frequency of false positive results for N3. We discuss these findings in the context of improvements to quality control, quality assurance, and assay validation practices that have since been improved at the CDC.

23 February 2019 in Mycoses
Verified
Journal Article
Closed access
PDF file
AAAusaf Ahmad
Ausaf Ahmad
JSJonathan E. Spencer
Jonathan E. Spencer
SLShawn R. Lockhart
Shawn R. Lockhart
SSSabrina Singleton
Sabrina Singleton
DPDavid J. Petway
David J. Petway
OHOwen T. Herzegh
Owen T. Herzegh

27 February 2023 in Genes
Verified
Journal Article
Open access
PDF file
AAAusaf Ahmad
Ausaf Ahmad
DNDingani Nkosi
Dingani Nkosi
MIM Anwar Iqbal
M Anwar Iqbal
The PARK2 gene is located on 6q26, encodes ubiquitin-E3- ligase, and is a transcriptional repressor of p53. It contains 12 exons. PARK2 copy number variants has been reported in various types of neurodevelopmental disorders, namely schizophrenia, Parkinson’s disease (PD), autism spectrum disorder (ASD), and attention-deficit/hyperactivity disorder (ADHD). In this retrospective study, nine cases (five with microdeletion and four with microduplication) are reported with 6q26 deletion disrupting the PARK2 gene. Microdeletion sizes ranged between 215 Kb and 356 Kb, and duplication between 279 Kb and 726 Kb. These were present within the exons 7–10. Family follow up with FISH probes revealed paternal inheritance in two cases, maternal in two cases, and de novo origin in one case. Our results support previous studies showing that patients with PARK2 CNVs involving exons 5–12 might be more deleterious and cause a unique syndrome. Comprehensive analysis of additional case studies is needed to have a full characterization of this neurological disorder syndrome.

29 December 2022 in Viruses
Verified
Journal Article
Open access
PDF file
CCCaitlin Cossaboom
Caitlin Cossaboom
NWNatalie Wendling
Natalie Wendling
NLNathaniel M. Lewis
Nathaniel M. Lewis
HRHannah Rettler
Hannah Rettler
RHRobert Reid Harvey
Robert Reid Harvey
CBCasey Barton Behravesh
Casey Barton Behravesh
From July–November 2020, mink (Neogale vison) on 12 Utah farms experienced an increase in mortality rates due to confirmed SARS-CoV-2 infection. We conducted epidemiologic investigations on six farms to identify the source of virus introduction, track cross-species transmission, and assess viral evolution. Interviews were conducted and specimens were collected from persons living or working on participating farms and from multiple animal species. Swabs and sera were tested by SARS-CoV-2 real-time reverse transcription polymerase chain reaction (rRT-PCR) and serological assays, respectively. Whole genome sequencing was attempted for specimens with cycle threshold values <30. Evidence of SARS-CoV-2 infection was detected by rRT-PCR or serology in ≥1 person, farmed mink, dog, and/or feral cat on each farm. Sequence analysis showed high similarity between mink and human sequences on corresponding farms. On farms sampled at multiple time points, mink tested rRT-PCR positive up to 16 weeks post-onset of increased mortality. Workers likely introduced SARS-CoV-2 to mink, and mink transmitted SARS-CoV-2 to other animal species; mink-to-human transmission was not identified. Our findings provide critical evidence to support interventions to prevent and manage SARS-CoV-2 in people and animals on mink farms and emphasizes the importance of a One Health approach to address emerging zoonoses.

27 September 2022 in Viruses
Verified
Journal Article
Open access
PDF file
BABrian R. Amman
Brian R. Amman
CCCaitlin Cossaboom
Caitlin Cossaboom
NWNatalie Wendling
Natalie Wendling
RHRobert Reid Harvey
Robert Reid Harvey
HRHannah Rettler
Hannah Rettler
JTJonathan Towner
Jonathan Towner
Zoonotic transmission of SARS-CoV-2 from infected humans to other animals has been documented around the world, most notably in mink farming operations in Europe and the United States. Outbreaks of SARS-CoV-2 on Utah mink farms began in late July 2020 and resulted in high mink mortality. An investigation of these outbreaks revealed active and past SARS-CoV-2 infections in free-roaming and in feral cats living on or near several mink farms. Cats were captured using live traps, were sampled, fitted with GPS collars, and released on the farms. GPS tracking of these cats show they made frequent visits to mink sheds, moved freely around the affected farms, and visited surrounding residential properties and neighborhoods on multiple occasions, making them potential low risk vectors of additional SARS-CoV-2 spread in local communities.

10 October 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TSTalya Shragai
Talya Shragai
CPCaroline Pratt
Caroline Pratt
JGJoaudimir Castro Georgi
Joaudimir Castro Georgi
MDMarisa A. P. Donnelly
Marisa A. P. Donnelly
NSNoah G. Schwartz
Noah G. Schwartz
TTthe COVID-19 Household Transmission Team
the COVID-19 Household Transmission Team
While risk of fomite transmission of SARS-CoV-2 is considered low, there is limited environmental data within households. This January—April 2021 investigation describes frequency and types of surfaces positive for SARS-CoV-2 by real-time reverse transcription polymerase chain reaction (RT-PCR) among residences with ≥1 SARS-CoV-2 infection, and associations of household characteristics with surface RT-PCR and viable virus positivity. Of 1232 samples from 124 households, 27.8% (n = 342) were RT-PCR positive with nightstands (44.1%) and pillows (40.9%) most frequently positive. SARS-CoV-2 lineage, documented household transmission, greater number of infected persons, shorter interval between illness onset and sampling, total household symptoms, proportion of infected persons ≤12 years old, and persons exhibiting upper respiratory symptoms or diarrhea were associated with more positive surfaces. Viable virus was isolated from 0.2% (n = 3 samples from one household) of all samples. This investigation suggests that while SARS-CoV-2 on surfaces is common, fomite transmission risk in households is low.